Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma
Clinical trial NCT02505750 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02505750
- Sponsor
- Centre Antoine Lacassagne
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-24
- Primary completion
- 2023-06-07
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.